HGG-21. GERMLINE MUTATIONS IN MSH2 GENE IN PEDIATRIC PATIENTS WITH CONGENITAL AND SPORADIC GLIOBLASTOMA

INTRODUCTION: Glioblastoma (GBM) remains one of the biggest therapeutic challenges in neuro-oncology. In spite of multimodal treatment approaches the prognosis of GBM is extremely poor, median survival is estimated about 12–16 months. Although GBM is one of the most common and malignant primary brai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Ejmont, Maria, Rydzanicz, Małgorzata, Grajkowska, Wiesława, Perek-Polnik, Marta, Sowińska, Agnieszka, Kozłowska, Magdalena, Łastowska, Maria, Pronicki, Maciej, Płoski, Rafał, Dembowska-Bagińska, Bożenna, Trubicka, Joanna
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
High Grade Glioma
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715741/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.308
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi